Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B

Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B

Despite the availability of an effective preventive vaccine for hepatitis B virus (HBV) for over 38 years, chronic HBV (CHB) infection remains a global health burden with around 257 million patients. The ideal treatment goal for CHB infection would be to achieve complete cure; however, current thera...

Full description

Bibliographic Details
Main Authors: Sayeh Ezzikouri, Mohammad Enamul Hoque Kayesh, Soumaya Benjelloun, Michinori Kohara, Kyoko Tsukiyama-Kohara
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Vaccines
Subjects:
HBV
innate immunity
adaptive immunity
host factors
therapeutic vaccine
Online Access:https://www.mdpi.com/2076-393X/8/2/216

Internet

https://www.mdpi.com/2076-393X/8/2/216

Similar Items